1922P Targeted resequencing designed specifically for thymic epithelial tumours confirmed the high prevalence of GTF2I mutations. - Petrini, I.; Pardini, E.; Cucchiara, F.; Sardo Infirri, G.; Burzi, I.S.; Barachini, S.; Monatli, M.; Maestri, M.; Ricciardi, R.; Nicolì, V.; Coppedè, F.; Bacchin, D.; et al. (Annals of Oncology, 2024)